One problem with small scale pilots of health provision is that you don't get the economy if scale to bring prices down and more importantly you don't have leverage at the research and price setting stages.
The nhs in the uk is one of the workd's biggest single employers and the purchasing power it wields gives it a lot weight with phaceutical companies. It's one of the reasons the uk punches far above its weight in research
And development if new drugs.
|